CTOs on the Move

Acadia Pharmaceuticals

www.acadia-pharm.com

 
Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson`s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome. And in early-stage clinical research, we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. Important Notice ...
  • Number of Employees: 250-1000
  • Annual Revenue: $250-500 Million
  • www.acadia-pharm.com
  • 3611 Valley Centre Drive Suite 300
    San Diego, CA USA 92130
  • Phone: 858.558.2871

Executives

Name Title Contact Details
Nick Condos
Head of Information Security/Sr. Director Information Security Profile
Jerry Cipriani
Director, IT Data Services Profile
Nick C
Head of Information Security/Sr. Director Information Security Profile
Mark Schneyer
Executive Vice President and Chief Financial Officer Profile
Kim Alexander
Senior Director of Information Technology Profile

Similar Companies

Antech Diagnostics

Antech sets the standard for reference laboratory and imaging excellence. At the heart of our company is our love for pets, their health, and their…

South Florida Institute For Reproductive Medicine

South Florida Institute For Reproductive Medicine is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.

Avoca Christian Church

Avoca Christian Church is a Bristol, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CORE Ingredients and Packaging

CORE Ingredients and Packaging is a Opa Locka, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.